By NewsDesk @infectiousdiseasenews
Effective pharmacologic treatments for COVID-19 remains a challenge. The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial showed dexamethasone, a steroid,...
On Tuesday, Vir Biotechnology & GSK announced the COMET-ICE study evaluating VIR-7831, a fully human anti-SARS-CoV-2 monoclonal antibody, will continue into Phase 3 based on an Independent Data Monitoring...
By NewsDesk @infectiousdiseasenews
Case count
In an update on the global COVID-19 pandemic, the Russia Ministry of Health has reported that the country’s total confirmed case count has topped...
Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial with approximately 440 patients to evaluate the use of hydroxychloroquine for...
The number of potential therapeutic options for treatment of COVID-19 is growing. Approaches include blocking SARS-CoV-2 from entering cells, disrupting the virus’ replication, antivirals, vaccines,...
The Food and Drug Administration (FDA) says they are committed to doing everything we can to provide timely response efforts to this pandemic and facilitate access to investigational drugs for use in...
Privacy Overview
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
